NCT06418919View on ClinicalTrials.gov

A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2025

Conditions
Relapsed Graves' DiseaseThyroid; Functional DisturbanceRadiofrequency Ablation Treatment
Interventions
PROCEDURE

Radiofrequency ablation treatment

RFA is used to ablate the entire thyroid gland

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER